Post by Jessie Lin Hui Li

Day 2 | Introductory Vaccinology Course: Basics for Vaccine Bioprocessing 💉🧪 From Bench to Bioreactor – The Reality Behind Vaccine Manufacturing A day where participants cracking their heads with the complicated upstream and downstream manufacturing processes. Today, they’ve learnt that manufacturing own vaccine isn’t easy 😆 yet, we all are still striving hard, not giving up. All we need is just more support, more involvement and more commitment from the nation. The morning kicked off with a comprehensive four-hour session led by Celene Xiao Ying LEE from NPRA, walking us through the upstream manufacturing journey — from GMP facilities, bioreactors, culture, harvesting, potential contamination to scale-up strategies. During the session, we were blessed to have a few local manufacturing experts from Pharmaniaga Berhad and Duopharma Biotech Berhad who shared their valuable manufacturing perspectives from industry practices and real world challenges. In the afternoon, Dr anuar jonet from NIBM Malaysia delivered another power-packed four-hour session on downstream processing. He also brought attention to the critical ‘Death Valley’ — the gap between academia research and industrial manufacturing. As he shared, NIBM is actively working to bridge this chasm, especially in microbial, mRNA, and egg-based vaccine platforms. What struck a chord with me in his speech was this reminder: 👉 Vaccine development is not a solo mission. It’s not about one agency, one researcher, or one company. It’s a shared responsibility — a national mission. And each of us, in our own capacity, has a role to play. See you all in Day 3 tomorrow 💉💊🦠 #IntroductoryVaccinologyCourse #BasicsforVaccineBioprocessing #Vaccinology #VaccineDevelopment #Bioprocessing #IVC2025